Erasca, Inc. (ERAS)
13.27
-0.10
(-0.75%)
USD |
NASDAQ |
Jun 11, 10:59
Erasca Market Cap : 4.124B for June 11, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Market Cap Data
| Date | Value |
|---|---|
| June 10, 2026 | 4.155B |
| June 09, 2026 | 4.168B |
| June 08, 2026 | 4.000B |
| June 05, 2026 | 3.720B |
| June 04, 2026 | 4.124B |
| June 03, 2026 | 4.096B |
| June 02, 2026 | 4.190B |
| June 01, 2026 | 4.295B |
| May 29, 2026 | 3.991B |
| May 28, 2026 | 3.792B |
| May 27, 2026 | 3.878B |
| May 26, 2026 | 3.576B |
| May 22, 2026 | 3.495B |
| May 21, 2026 | 3.609B |
| May 20, 2026 | 3.458B |
| May 19, 2026 | 3.209B |
| May 18, 2026 | 3.194B |
| May 15, 2026 | 3.181B |
| May 14, 2026 | 3.225B |
| May 13, 2026 | 3.253B |
| May 12, 2026 | 3.228B |
| May 11, 2026 | 3.247B |
| May 08, 2026 | 3.147B |
| May 07, 2026 | 3.234B |
| May 06, 2026 | 3.390B |
| Date | Value |
|---|---|
| May 05, 2026 | 3.105B |
| May 04, 2026 | 3.152B |
| May 01, 2026 | 3.117B |
| April 30, 2026 | 3.310B |
| April 29, 2026 | 2.831B |
| April 28, 2026 | 3.077B |
| April 27, 2026 | 5.952B |
| April 24, 2026 | 6.679B |
| April 23, 2026 | 6.984B |
| April 22, 2026 | 6.729B |
| April 21, 2026 | 6.965B |
| April 20, 2026 | 6.747B |
| April 17, 2026 | 5.908B |
| April 16, 2026 | 5.666B |
| April 15, 2026 | 5.657B |
| April 14, 2026 | 5.548B |
| April 13, 2026 | 5.069B |
| April 10, 2026 | 5.287B |
| April 09, 2026 | 5.395B |
| April 08, 2026 | 5.265B |
| April 07, 2026 | 5.302B |
| April 06, 2026 | 5.321B |
| April 02, 2026 | 5.535B |
| April 01, 2026 | 5.159B |
| March 31, 2026 | 5.029B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Revolution Medicines, Inc. | 29.22B |
| Tango Therapeutics, Inc. | 4.081B |
| Kymera Therapeutics, Inc. | 6.651B |
| Bridgebio Oncology Therapeutics, Inc. | 595.06M |
| ImmunityBio, Inc. | 7.452B |
Market Cap Related Metrics
| PEG Ratio | -0.2874 |
| Price to Book Value | 10.48 |
| Price | 13.27 |
| Earnings Yield | -7.03% |
| PEGY Ratio | -0.2874 |